Stock listing
SPRY Stock Price, News, Filings & Events — Ars Pharmaceuticals, Inc.
Selected listing: SPRY · NASDAQ · USD · US
This page tracks Ars Pharmaceuticals, Inc.'s SPRY:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SPRY:NASDAQ. SPRY:NASDAQ is the stock-level entry point for investors researching Ars Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ars Pharmaceuticals, Inc. is a public company traded under the ticker SPRY in the American market. The company has a market capitalization of approximately $589.9 million. It focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- SPRY:NASDAQ
- Asset type
- Stock
- Market cap
- $473.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Ars Pharmaceuticals, Inc. SPRY:NASDAQ stock context
This page tracks Ars Pharmaceuticals, Inc.'s SPRY:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SPRY:NASDAQ. SPRY:NASDAQ is the stock-level entry point for investors researching Ars Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ars Pharmaceuticals, Inc. is a public company traded under the ticker SPRY in the American market. The company has a market capitalization of approximately $589.9 million. It focuses on developing innovative therapies to address unmet medical needs.
Latest news from Ars Pharmaceuticals, Inc.
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Res...
August 13, 2026
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Qu...
August 3, 2026
ARS Pharmaceuticals Announces CEO Succession
July 7, 2026
ARS Pharmaceuticals Provides Commercial and Financial Updates
June 24, 2026
Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies
June 4, 2026
Ars Pharmaceuticals, Inc. earnings calls
ARS Pharmaceuticals, Inc. (SPRY) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
ARS Pharmaceuticals, Inc. (SPRY) Q1 2026 Earnings Call
May 15, 2026 · Replay with transcript and chapters
ARS Pharmaceuticals, Inc. (SPRY) Q4 2025 Earnings Call
March 9, 2026 · Replay with transcript and chapters
ARS Pharmaceuticals, Inc. (SPRY) Q3 2025 Earnings Call
November 10, 2025 · Replay with transcript and chapters
ARS Pharmaceuticals, Inc. (SPRY) Q2 2025 Earnings Call
August 13, 2025 · Replay with transcript and chapters
ARS Pharmaceuticals, Inc. (SPRY) Q1 2025 Earnings Call
May 14, 2025 · Replay with transcript and chapters
Research Ars Pharmaceuticals, Inc.
Ars Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for SPRY:NASDAQ.
Ars Pharmaceuticals, Inc. company profile
View the public company page for Ars Pharmaceuticals, Inc. on 6ix.
Ars Pharmaceuticals, Inc. news
Read company news and market updates connected to Ars Pharmaceuticals, Inc..
Ars Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Ars Pharmaceuticals, Inc..